Indirect UO2 oxidation by Mn(II)-oxidizing spores of Bacillus sp. strain SG-1 and the effect of U and Mn concentrations.
Manganese oxides are widespread in the environment and their surface reactivity has the potential to modifythe geochemical behavior of uranium. We have investigated the effect of different concentrations of U and Mn on the coupled biogeochemical oxidation-reduction reactions of U and Mn. Experiments conducted in the presence of Mn(II)-oxidizing spores from Bacillus sp. strain SG-1 and 5% headspace oxygen show that the Mn oxides produced by these spores can rapidly oxidize UO2. Thirty to fifty times more UO2 is oxidized in the presence of Mn oxides compared to Mn oxide free controls. As a consequence of this U02 oxidation, Mn oxides are reduced to soluble Mn(II) that can be reoxidized by SG-1 spores. SG-1 spores cannot directly oxidize U02, but U02 oxidation proceeds rapidly with Mn(II) concentrations of <5 microM. The rate of UO2 oxidation is equal to the rate of MnO2 reduction with UO2 oxidation controlled by the initial concentrations of UO2, dissolved Mn(II) (in systems with spores), or Mn(IV) oxides (in systems containing preformed MnO2). U(VI) and UO2 decrease the Mn(II) oxidation rate in different ways by inhibiting the Mn(II)-oxidizing enzyme or decreasing the available Mn(II). These results emphasize the need to consider the impact of Mn(II)-oxidizing bacteria when predicting the potential for U02 oxidation in the subsurface.
Chinni
Satyavathi
S
Division of Environmental and Biomolecular Systems, Oregon Health & Science University, 20000 NW Walker Road, Beaverton, Oregon 97006, USA. chinnis@ebs.ogi.edu
Anderson
Craig R
CR
Ulrich
Kai-Uwe
KU
Giammar
Daniel E
DE
Tebo
Bradley M
BM
D001407:Bacillus / Q000187:drug effects* / Q000378:metabolism*; D001673:Biodegradation, Environmental / Q000187:drug effects; D002384:Catalysis / Q000187:drug effects; D004777:Environment; D007700:Kinetics; D008345:Manganese / Q000378:metabolism* / Q000494:pharmacology*; D017895:Manganese Compounds / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D010087:Oxides / Q000378:metabolism; D013171:Spores, Bacterial / Q000187:drug effects / Q000378:metabolism*; D014501:Uranium / Q000494:pharmacology*; D017974:Uranium Compounds / Q000378:metabolism*
D017895:Manganese Compounds; D010087:Oxides; D017974:Uranium Compounds; D008345:Manganese; D014501:Uranium; C027424:manganese oxide; C012597:uranium dioxide